PCM
EXAS

Perkins Capital Management’s Exact Sciences EXAS Stock Holding History

Perkins Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-21,700
Closed -$256K – 135
2013
Q3 		$256K Sell
21,700
-18,100
-45% -$232K 0.18% 98
2013
Q2 		$554K Buy
+39,800
New +$432K 0.44% 75

Other funds holding EXAS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Perkins Capital Management's EXAS Position: Q4 2013 in Review

Perkins Capital Management sold out of Exact Sciences (EXAS) in Q4 2013, closing a stake of 21,700 shares — an estimated $256K sold.

Perkins Capital Management first reported a position in EXAS in Q2 2013 and held it in 2 quarters. The position peaked at $554K in Q2 2013. 131 funds tracked by Wall St. Rank hold EXAS as of Q4 2013.

  • Perkins Capital Management reported no remaining Exact Sciences position as of Q4 2013 after selling out during the quarter.
  • Perkins Capital Management sold 21,700 Exact Sciences shares in Q4 2013, an estimated $256K.
  • Perkins Capital Management first reported a position in Exact Sciences in Q2 2013 and held it in 2 quarters.
  • Perkins Capital Management's Exact Sciences position peaked at $554K in Q2 2013.
  • 131 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2013.

Based on Perkins Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.